Previous 10 | Next 10 |
BiondVax Pharmaceuticals (NASDAQ:BVXV) +55% signs definitive agreements for development and commercialization of innovative nanosized COVID-19 antibody therapy with Max Planck Institute of Biophysical Chemistry and University Medical Center Göttingen, Germany. BioRestorative Therapi...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oracle (NYSE: ORCL ) stock is on the rise Friday thanks to the computer tech company’s earnings report for its fiscal second quarter of 2022. Source: JHVEPhoto / Shutterstock.com Let’s break down...
Gainers: Petros Pharmaceuticals (NASDAQ:PTPI) +37%, Biofrontera BFRI +20%, ABVC BioPharma (NASDAQ:ABVC) +12%, Halozyme Therapeutics (NASDAQ:HALO) +11%, Context Therapeutics CNTX +9%. Losers: Angion Biomedica (NASDAQ:ANGN) -22%, Ensysce Biosciences ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Everbridge (NASDAQ: EVBG ) stock is taking a beating on Friday following news of its CEO leaving the software company. Source: monticello / Shutterstock.com Let’s dive into everything investors need to...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips MeaTech3D (NASDAQ: MITC ) stock is heating up today following news of a breakthrough in its lab-grown steak efforts. Source: Joshua Resnick / Shutterstock.com MeaTech3D revealed the successful printing of a 3...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Context Therapeutics (NASDAQ: CNTX ) stock is rising higher on Friday thanks to results from a Phase 0 clinical trial. Source: Shutterstock That trial saw the company treating 10 women suffering from breast c...
Context Therapeutics (NASDAQ:CNTX) +25% on positive ONA-XR data in early breast cancer study. American Virtual Cloud Technologies (NASDAQ:AVCT) +25% Kandy and Braidio announce expanded partnership to accelerate the delivery of digital transformation as a service solutions. Ener...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! It’s the last day of the trading week and we’re starting it with the biggest pre-market stock movers for Friday! Source: Shutterstock Stocks are on the move this morning thanks ...
Context Therapeutics (NASDAQ:CNTX) surged 40.6% after-hours following positive onapristone extended release (ONA-XR) data in postmenopausal patients with progesterone receptor positive (PR+) early breast cancer. ONA-XR significantly increased suppression of tumor cell prol...
Data demonstrated ONA-XR decreased proliferation in tumors with high PR+ at baseline in early breast cancer Two additional metastatic breast cancer clinical trials in progress also presented PHILADELPHIA, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (Nasdaq:...
News, Short Squeeze, Breakout and More Instantly...
Context Therapeutics Inc. Company Name:
CNTX Stock Symbol:
NASDAQ Market:
Context Therapeutics Inc. Website:
CT-95 is a potentially first-in-class mesothelin x CD3 bispecific antibody Acquisition expands Context pipeline with second clinical-stage T cell engager for solid tumors PHILADELPHIA, July 10, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the ...
Announced FDA clearance of IND application for a Phase 1 clinical trial of CTIM-76 Completed $100 million financing; expected to extend funding into 2028 PHILADELPHIA, May 08, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”...